A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.

NCT07053137 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
180
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Yipeng Liu

Collaborators